purpose make world smarter happier richer founded motley fool financial service company dedicated making world smarter happier richer motley fool reach million people every month premium investing solution free guidance market analysis foolcom toprated podcasts nonprofit motley fool foundation purpose make world smarter happier richer founded motley fool financial service company dedicated making world smarter happier richer motley fool reach million people every month premium investing solution free guidance market analysis foolcom toprated podcasts nonprofit motley fool foundation shc earnings call period ending december image source motley fool sotera health shc q earnings callfeb etcontents prepared remark question answer call participant prepared remark operatorgood morning welcome sotera health fourth quarter full year conference call participant listenonly mode operator instruction today presentation opportunity ask question operator instruction please note event recorded would like turn conference vice president treasurer mr jason peterson please go aheadjason peterson vice president treasurer thank good morning welcome today call find today press release accompanying supplemental slide investor section website soterahealthcom webcast recorded replay available investor section sotera health website call today chairman chief executive officer michael petras chief financial officer jon lyon call comment may considered forwardlooking statement matter addressed statement subject risk uncertainty could cause actual result differ materially projected implied please refer sotera health sec filing forwardlooking statement slide beginning presentation description risk uncertaintiesthe company assumes obligation update forwardlooking statement please note discussion today company present gaap nongaap financial measure including adjusted ebitda adjusted net income tax rate applicable adjusted net income adjusted eps adjusted ebitda margin segment income margin net debt net leverage ratio well constant currency comparison reconciliation gaap nongaap measure relevant period may found schedule attached company press release supplemental slide presentation operator assisting qa portion call today please limit one question one followup try give everyone opportunity ask question always question postcall please feel free reach investor relation team turn call sotera health chairman ceo michael petras michael petras chairman chief executive officer good morning everyone welcome today call morning reported top bottomline growth quarter full year delivering plus adjusted ebitda margin presented many challenge including macroeconomic customer supply chain pressure shifting regulatory landscape lumpy cobalt harvest schedule nordion throughout year sotera health team demonstrated resiliency adaptability unwavering commitment company core value face challenge addition growth delivered successful achieving number operational goal sterigenics completed four capacity expansion made significant progress yous eo facility enhancement nordion team secured cobalt supply successfully delivered full year revenue fourth quarter team also made good progress longterm cobalt development program nelson lab achieved significant growth technical advisory service area throughout year rca business acquired continues deliver strong revenue growth rca support customer interaction regular regulatory agency fda also resolved substantial amount ethylene oxide litigation illinois settlement claimant well recent settlement approximately personal injury claim georgia finished strong liquidity position approximately million liquidity increase million end jon provide detail financial result moment first want highlight item fourth quarter full year result reported total revenue growth adjusted ebitda growth compared fourth quarter full year revenue grew adjusted ebitda grew compared mark another year continue streak annual revenue growth achieved every single year since respect business unit sterigenics delivered topline growth quarter full year discussed previously sterigenics largest reporting segment delivered consistent growth throughout history serving customer base comprehensive global network facility segment delivered compound annual growth rate top line bottom line since becoming public company growth rate speak durability business model sterigenics provide critical often governmentmandated service represents fraction overall product cost customer nordion business within sterilization service segment delivered revenue growth quarter performance expected driven timing cobalt harvest schedule consistently messaged nordions revenue tied harvest schedule cobalt supplier result irregular revenue pattern quartertoquarter basis team unique expertise navigating complex cobalt supply chain stated earlier nordion team fantastic job delivering full year revenue fourth quarter full year basis nordion revenue revenue nelson lab lab testing advisory service business grew quarter versus fourth quarter full year revenue approximately versus prior year nelson lab continues face headwind referenced third quarter call including extension compliance deadline european union medical device regulation decline funding startup smaller company lastly softened demand routine lot release testing tied slowed sterilization volume overall good year sotera health considering uncertainty driven macroeconomic pressure customer inventory destocking geopolitical event also want take moment highlight progress made corporate responsibility initiative proud team accomplishment since ipo part ipo board established esg oversight within nominating corporate governance committee also established internal crossfunctional committee report appointed two seasoned senior executive cochairs lead identification implementation initiative consistent overall business strategy built initiative begun highlight accomplishment include environmental area working thirdparty software solution establish first time publish baseline environmental metric previously mentioned continue investment industryleading stateoftheart emission control yield facility also published first environmental management statement corporate responsibility report respect human capital culture community published formal human right statement disclosed initial human capital data completed global employee engagement survey participation rate sotera health woman network held interactive session leader board director ann klee proud announce woman represented global leadership promotion governance side welcomed karen flynn board karen brings board independence add valuable commercial experience pharma service space important aspect longterm strategy also launched formal enterprise risk management process result led u prioritize six initial area six area highlighted corporate responsibility report finally team completed outreach institution holding company public stock float held meeting esg topic institution holding approximately public float greatly value discussion share feedback regularly board director including past week look forward continuing share corporate responsibility accomplishment future earlier today provided initial outlook full year expect deliver another year top bottomline growth total revenue adjusted ebitda growth expected range compared variability within full year revenue range largely driven timing magnitude market recovery sterigenics nelson lab jon take u financials depthjon lyon chief financial officer thank michael first cover fourth quarter full year result including update capital deployment leverage conclude additional detail outlook consolidated total company basis fourth quarter revenue grew constant currency basis million fourth quarter volume growth abnormally high nordions full year revenue landing period michael previously mentioned fourth quarter adjusted ebitda grew million adjusted ebitda margin expanded almost basis point reported interest expense quarter million reported net income fourth quarter million per diluted share adjusted eps quarter increase let u take look segment performance fourth quarter fourth quarter sterigenics delivered revenue growth million revenue growth driver quarter included favorable pricing favorable change foreign currency exchange rate partially offset slightly unfavorable volume mix approximately segment income grew million driven favorable pricing change foreign currency exchange rate partially offset higher cost unfavorable volume mix nordions fourth quarter revenue increased approximately million driven favorable volume mix pricing nordion generated full year revenue quarter expected segment income increased million segment income margin expanded basis point nelson lab returned growth fourth quarter revenue improved million compared quarter last year revenue growth driven favorable pricing foreign currency tailwind partially offset unfavorable volume mix segment income decreased million segment income margin declined basis point driven unfavorable volume mix coupled inflationary pressure partially offset favorable pricing full year delivered billion revenue constant currency basis grew adjusted ebitda million resulting adjusted ebitda margin reported interest expense full year approximately million reported net income million per diluted share adjusted eps year per weighted average diluted share decrease primarily driven higher interest expense higher tax rate turn liquidity net leverage capital deployment company continues strong liquidity position yearend approximately million available liquidity included million unrestricted cash million available capacity revolving line credit adjusting million illinois settlement generated million operating cash line prior year demonstrates cashgenerating strength business net leverage ratio finished year time within target range two four time may recall net leverage ratio increased time second quarter financing million term loan subsequent million illinois settlement payment since q net leverage ratio improved nearly half turn demonstrates ability delever growth capex year finished million michael mentioned sterigenics completed four capacity expansion year made significant progress eo facility enhancement currently three growth project process two greenfields nordions cobalt development program progressing well mentioned q call onceinageneration longterm project yield incremental cobalt later decade nelson lab continue invest expanding pharma capability lab lab information management system deploying across business segment would like discus outlook full year expect total revenue adjusted ebitda grow range adjusted ebitda margin similar level expect another year solid price performance lower end longterm stated range due moderation inflation timing longterm contract renewal nordion revenue cadence perspective q typically lightest quarter year company expect case sterigenics assuming relatively flat volume first half slight recovery beginning second half versus nordion revenue balanced first half second half first quarter lightest quarter year stronger nelson lab revenue first half year slightly lower back half first quarter historically lightest quarter year past couple year provided visibility revenue risk associated russian cobalt supply today approximate risk total company revenue point would like direct slide earnings presentation posted investor website event presentation outline change making calculation adjusted net income way background q closed million term loan fund million illinois eo settlement consistent treatment eo litigationrelated cost excluded interest cost related million loan calculate adjusted net income beginning longer make adjustment presented impact change would right basis comparison going forward see slide adjusted net income reduced million million effective tax rate applicable adjusted net income increased adjusted eps change per weighted average diluted share appropriate basis comparison tax rate eps guidance expect interest expense million million projecting effective tax rate applicable adjusted net income range adjusted eps expected range expect fully diluted share count range million million share weighted average basis capital deployment standpoint continue prioritize organic growth deleveraging well opportunistic expect capital expenditure range million million previously communicated expect elevated level start see decline capex spending start see free cash flow generation accelerate finally guidance assume anticipate net leverage improve turn call back michael closing remarksmichael petras chairman chief executive officer thank jon look forward continue focus priority priority include expanding global network disciplined investment cobalt development additional capacity continue invest upgrade yous eo emission control system enhance onecompany capability crossfunctional business unit initiative delivering top bottomline growth strong cash flow generation want reemphasize strength durability business model expect another good year performance spite uncertain demand recovery fundamental criticality service remain intact customer longterm relationship top medical device pharma company world supported multiyear contract continue execute customer market volume improve sotera health benefit recovery focus day day mission safeguarding global health company play critical role healthcare strong position growth point operator let u open call qa question answer operatorthank begin questionandanswer session operator instruction first question come sean dodge rbc capital please go aheadsean dodge rbc capital market analyst yeah thanks good morning want start sterigenics michael said guidance assumes volume recovery second half year give u sense proportion sterigenics revenue expecting first half second half guess historically second half always bigger term revenue going lot pronounced maybe could talk visibility expecting market recovery something else seeing indicates thatmichael petras chairman chief executive officer yeah good morning sean yes similar seen past second half know typically little bit better first half think going dramatic said relatively flat volume first half sterigenics improving second half know really trying predict say comment around recovery market volume still see destocking occurring channel tell overall seeing get worse stable sterigenics side well nelson side getting worse question recovery start come back want give visibility thinking year play outsean dodge rbc capital market analyst ok great nelson maybe update margin outlook aside volume coming cost action take lever start pull drive improvement margin nelson businessmichael petras chairman chief executive officer yeah mentioned past sean got position early probably overresourced based volume eye toward better service making sure volume came back people place really take care business would tell see improvement year progress know going get turnover business work going backfilling many job see volume recover know goal get mids mentioned take u time get ultimately aspiration timesean dodge rbc capital market analyst okmichael petras chairman chief executive officer know fine line sean want make sure service customer biggest thing volume come ok thank youoperatorthe next question come dave windley jefferies please go aheaddave windley jefferies analyst hi good morning thanks taking question michael want start little bit strategic question longterm cobalt supply initiative working successful know know development work around new reactor thing like impact guess know kind fairly stable predictable growth rate know certain amount medtech us know inaudible sterilization would expect lower input cost would compete price market share allow supply serve volume serving today guess wondering know really discussed think much length far away lever get cobalt supplymichael petras chairman chief executive officer yeah david thanks question folk familiar know cobalt development program really focused around working opg ontario power group one longestterm supplier getting capacity well program working westinghouse goal program able keep market growth time portion replaces existing reactor go service know maintenance work retired importantly also bring additional capacity longerterm flexibility global supply chain think ultimately david needed keep market growth long rundave windley jefferies analyst ok maybe sterigenics following seans question volume destocking seeing sound like emphasized getting worse good news visibility customer know much destocking need quantification give comfort know volume kind correlation order pattern underlying medtech order pattern might start know tighten little bit second halfmichael petras chairman chief executive officer yeah david know pretty complicated supply chain customer inventory distribution channel well health system seeing get worse stated one example would know meant late year actually sorry beginning year one know major medtech customer ceo said listen took million inventory back half year focus working capital right saw seeing across multiple customer think maybe follow medtech space see well bioprocessing space well people taking trying get back precovid level slightly mentioned seeing get worse able draw great correlation square david pocket u seeing stabilize seeing get worse starting see little bit recovery feel pretty confident calling visibility year sterigenics really tied volume feel good ability volume come going position service help u get margin improvement time welldave windley jefferies analyst great appreciate answer thank youoperatorthe next question come luke sergott barclays please go aheadluke sergott barclays analyst great thanks guy want follow destocking mean dealing bioprocessing side seeing device way guy could estimate like much stocked know normal cadence know like full year stocked working know six month something like get understand going call timing magnitude like going back history ever seen anything like know kind use frameworkmichael petras chairman chief executive officer luke unfortunately like think struggling look big medtech company pharma company right global nature get multiple product line pharma med device look conversation look public filing around inventory level day sale hand know try best job talked lot investor struggle looking customer base would tell see getting worse would part want leave continue work overall throughout channelsluke sergott barclays analyst right great margin guidance flat margin year year know volume come back back half growth accelerates throughout year know obviously pacing pick margin wondering getting back normalized level know investment standpoint guy bucket like put take margin dynamic throughout yearmichael petras chairman chief executive officer yeah know would look look margin pretty consistent slightly kind guide lead focused really driving margin dollar growth necessarily rate expansion time get operating leverage mentioned minute ago think help u margin improvement right guide expecting flat margin plus percentluke sergott barclays analyst ok thanksoperatorthe next question come brett fishbin keybanc please go aheadbrett fishbin keybanc capital market analyst hey guy thanks much taking question wanted start one followup around revenue growth guidance hoping could walk moving piece particularly around nelson lab nordion thought year think gave commentary phasing maybe could give little bit full year expectation think whether step nelson lab performance q could proceed michael petras chairman chief executive officer yeah brett know think predicated volume recovery stated remark plus minus around guide given expect know nelson continue improve time good growth rca business able help u offset volume inaudible side also mentioned mdr compliance timing played nordion nordion know consistent performer u lightest quarter first quarter saw last year know last year really slow quarter overall going result know growth rate slightly better saw last year nordion businessbrett fishbin keybanc capital market analyst right thanks color one followup maybe could give little bit thinking free cash flow setup think know obviously pretty big adjustment moving piece around settlement maybe outside anything know changing significantly thinking outside ongoing capex project going thank youjon lyon chief financial officer yeah brett thanks question jon lyon know see favorable position free cash flow year think pull settlement somewhere around million million know couple moving piece inside look going number one georgia settlement paid january moving piece interest going slightly elevated year compared last tax slightly elevated flip side ebitda growth generate cash le headwind working capital going year focused generating free cash flow know keep driving know said q see capex coming next couple year free cash flow performance really accelerate move brett fishbin keybanc capital market analyst right thanks taking question appreciate itjon lyon chief financial officer thanks brettoperatorthe next question come casey woodring jp morgan please go aheadcasey woodring jpmorgan chase company analyst hi thank taking question follow capex guide million million year floor could finalized neshap ruling drive high potentially maybe break u much number eo facility enhancement versus capacity expansion project cobalt development program underway know mentioned elevated capex year take step give u sense many cost year nonrepeatingmichael petras chairman chief executive officer casey guess got one question compound try answer best expecting guide capex got million gfp cobalt development significant know investment year stated know last year year biggest year around far neshap expect hear something neshap sometime month march could early march waiting final guide government could incremental cost depending exactly come based know today feel pretty confident position ability meet requirement took industryleading approach trying resolve emission challenge expected epa overall feel pretty good cap guide giving think got questionscasey woodring jpmorgan chase company analyst got itmichael petras chairman chief executive officer several sorry missed onecasey woodring jpmorgan chase company analyst yeah helpful followup completed four sterigenics capacity expansion project three left finish think mentioned conference last month one coming online quarter curious quantify increase overall sterigenics capacity end expansion project could walk capacity utilization expectation softer volume environment weighing margin would create easier comp demand normalizes thank youmichael petras chairman chief executive officer ok yes one three capacity project process coming live first quarter get particular much incremental capacity generate market overall try get commitment customer approximately expansion mean happens everyone guide would tell look know program one come year one late one think got capacity utilization think question target casey woodring jpmorgan chase company analyst ok got thank youoperatorthe next question come patrick donnelly citi please go aheadpatrick donnelly citi analyst hey guy thanks taking question michael maybe one pricing side sound like year going little low end kind longterm algorithm know touched timing stuff know want kind talk hearing customer core business sound like nordion piece maybe dragging little bit hearing pricing right way think going forward beyond year wellmichael petras chairman chief executive officer yeah patrick thanks question yeah feel confident wanted signal year could lower end range driven point referenced longer term nature longerterm contract nordion rolled strong nordion price performance soften little bit concerned longrange ability generate price based value proposition offer customerspatrick donnelly citi analyst ok helpful sound like know past couple quarter maybe good dialogue investor obviously pretty concentrated holding top mean intel insight kind initial holder kind thinking term know potentially know thing like secondary thing like term concentration holding top given seem like chatted good amountmichael petras chairman chief executive officer yeah well board chat quite bit know end day shareholder got make decision sell stock going reckless thoughtful great investment supportive company time eventually sell position know private equity firm overall thoughtful ramp want make sure reckless mannerpatrick donnelly citi analyst understood thanks michaelmichael petras chairman chief executive officer thanks patrickoperatorthe next question come michael polark wolfe research please go aheadmike polark wolfe research analyst thank good morning nordion q look hear thematic comment range could paint could drive bus like right number nordion revenue first quarter look million million something like quite highmichael petras chairman chief executive officer yeah know michael going get particular individual business quarter last year high way would think know last year really abnormally low came position recall last year hardly inventory coming yearmike polark wolfe research analyst followup belowtheline interest expense tax question tax tax rate high path get lower interest expense trying bridge jon hear comment clear illinois excluded last year included year million interest expense last year illinois probably guiding else going cycling kind higher rate generally overall balance modeling incremental draw point year want fully understand bridge interest expensejon lyon chief financial officer yeah thanks question want make sure folk understand clarify know look reported today eps adjusted basis make adjustment right new baseline comparison yeah tax adjustment stick little bit leading higher tax rate trick tax rate elevated excess interest expense deduct yous tax purpose outlook able deduct future get benefit take valuation allowance lead u higher tax rate know continuing grow path reducing tax rate time lowering thing like interest expense drive yous tax taxable yous taxable income ability use interest deduction help improve itmichael petras chairman chief executive officer mike thing would add incremental new debt contemplated guide number finished last year compared guide timing run loan put last year rolling full year also higher interest rate environment allmike polark wolfe research analyst got thank youmichael petras chairman chief executive officer ok great question operator chuckoperatorthat would like pas call back mr petras closing remark michael petras chairman chief executive officer great thank everybody getting together morning see really proud accomplished excited optimistic great business play critical role healthcare sticky customer relationship continue bring real value customer day day really providing safe environment employee patient community operate really proud team look forward conversation thank great day byebyeoperatoroperator signoff duration minutescall participantsjason peterson vice president treasurermichael petras chairman chief executive officerjon lyon chief financial officersean dodge rbc capital market analystdave windley jefferies analystluke sergott barclays analystbrett fishbin keybanc capital market analystcasey woodring jpmorgan chase company analystpatrick donnelly citi analystmike polark wolfe research analyst shc analysis earnings call transcript article transcript conference call produced motley fool strive foolish best may error omission inaccuracy transcript article motley fool assume responsibility use content strongly encourage research including listening call reading company sec filing please see term condition additional detail including obligatory capitalized disclaimer liabilitythe motley fool position stock mentioned motley fool disclosure policy